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ABSTRACT
The knee is a frequent target for gout 
and calcium pyrophosphate dihydrate 
(CPPD) disease with involvement of 
both articular and peri-articular struc-
tures. The aims of the present study 
were to investigate the relationship 
between clinical and ultrasound (US) 
findings and to describe the prevalence 
and distribution of crystal deposits 
in the knee in patients with gout and 
CPPD disease. Thirty patients with 
gout and 70 patients with CPPD dis-
ease were enrolled in the study. Prior to 
US assessment all patients underwent a 
clinical examination by an expert rheu-
matologist who recorded the presence/
absence of pain, tenderness (evocated 
by palpation and/or active or passive 
mobilisation of the knee), and knee 
swelling. US examinations were per-
formed using a Logiq 9 (General Elec-
tric Medical Systems, Milwaukee, WI) 
equipped with a multifrequency linear 
probe, working at 9 MHz. Two hundred 
knee joints were investigated in a total 
of 100 patients. Fifty-one (25.5%) knee 
joints were found clinically involved, 
while at least one US finding indicative 
of joint inflammation was obtained in 
73 (36.5%) knee joints.
The most frequent US finding indica-
tive of knee joint inflammation was 
joint effusion, detected in 21 (35%) out 
of 60 knees and in 52 (37%) out of 140 
knees, in gout and CPPD disease, re-
spectively. Ten (17%) out of 60 knees 
and 21 (15%) out of 140 knees were 
found positive for synovial hypertrophy 
with or without intra-articular power 
Doppler, in gout and CPPD disease 
respectively. Sonographic evidence of 
crystal deposition within joint carti-
lage (hyaline and fibrocartilage) was 
more frequently seen than in the soft 
tissue in the knee.
This study demonstrated that US de-
tected a higher number of inflamed 
knee joints than clinical assessment in 
patients with crystal related arthropa-
thies and that the distribution of crystal 
deposits at joint cartilage level permit-
ted distinction between gout and CPPD 
disease. Further studies are required to 
investigate both sensitivity and specifi-
city of US features indicative of crystal 
aggregates at both tendon and enthe-
seal level.
Introduction
Although ultrasound (US) is widely 
considered to be an excellent technique 
for quick and accurate assessment of 
patients with various rheumatic dis-
eases (1-8), only few studies have ad-
dressed its diagnostic ability in crystal- 
related arthropathies (9-18).
The knee is a frequent target for gout 
and calcium pyrophosphate dihydrate 
CPPD disease with involvement of both 
articular and peri-articular structures 
(19).
The aims of the present study were to 
investigate the relationship between 
clinical and US findings and to describe 
the prevalence and distribution of crys-
tal deposits in the knee in patients with 
gout and CPPD disease.
Methods
The study was conducted according to 
the Declaration of Helsinki and local 
regulations and informed consent was 
obtained from all patients.
Patients
Thirty patients with gout and 70 patients 
with CPPD disease, attending the out-
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patient clinics and in-patient facilities 
of the Rheumatology Departments in-
volved in this multicentre observational 
study were consecutively enrolled in the 
study. The diagnoses have been formu-
lated according to international criteria: 
the American Rheumatism Association 
guidelines for gout and McCarty crite-
ria for CPPD disease (20, 21). Patients 
with a history of severe trauma or knee 
surgery were not included in the study. 
Demographic and clinical characteris-
tics of the study population are reported 
in Table I.
Study design
Prior to US assessment all patients un-
derwent a clinical examination by an 
expert rheumatologist who recorded the 
presence/absence of pain, tenderness 
(evocated by palpation and/or active or 
passive mobilisation of the knee), and 
knee swelling.
All US examinations were performed 
by experienced sonographers, one for 
each centre involved in the study. Pa-
tients were asked not to talk about 
their clinical condition with the sonog-
raphers who were blind to both clini-
cal and laboratory data. Sonographers 
reached a consensus on both the scan-
ning technique to adopt and the patho-
logical findings to report in advance.
US scanning technique
US examinations were performed us-
ing a Logiq 9 (General Electric Medi-
cal Systems, Milwaukee, WI) equipped 
with a multifrequency linear probe, 
working at 9 MHz.
All the knee US examinations were 
performed using a multiplanar tech-
nique adopting the indications provided 
by the EULAR guidelines for muscu-
loskeletal ultrasound in rheumatology 
(22). Additional scans, performed to 
assess a wider cartilage surface, includ-
ed medial para-patellar views, which 
were carried out with knee in maximal 
flexion. The inclination of the US beam 
was adjusted in order to be perpendicu-
lar to the cartilage surface. Dynamic 
examination during both compression 
with the probe and flexion-extension of 
the knee, was carried out to identify the 
superficial margin of the hyaline carti-
lage. Lateral and medial longitudinal 
Table I. Demographic and clinical data.
 Gout CPPD disease 
Number of patients 30 70
Gender (female/male) 2/28 55/25
Age in years 59; 56-66; 10.6; 42-79. 66; 62-68; 9.8; 36-84. 
   (median; 95% CI for the median; SD; range) 
Disease duration in years 6; 5-7; 4.2; 3-20. 6; 5-7; 5.8; 2-30. 
   (median; 95% CI for the median; SD; range)  
 
CI: confidence interval; SD: standard deviation.
Table II. Scanning technique adopted for the study.
Scanning planes Position of the patient Anatomic structures 
under examination
Anterior transverse and  Patient in supine position with Supra-patellar pouch
   longitudinal scans the knee in neutral extended  Quadriceps and patellar
 position and with the knee  tendons and entheses
 semiflexed at 45° 
Anterior supra-patellar transverse Patient in supine position  Hyaline cartilage of the
   and longitudinal scans with the knee in maximal femoral trochlea and the 
 flexion (>90°) anterior portion of the femoral 
  condyles
Anterior para-patellar transverse Patient in supine position The lateral portion of the 
   and longitudinal scans with the knee in maximal  hyaline cartilage of the
 flexion (>90°) femoral condyles
Lateral and medial transverse and Patients in supine position The external portion of the 
   longitudinal scans with the knee in neutral  menisci
 extended and in maximal 
 flexion positions.
Posterior transverse and Patient in prone position with Hyaline cartilage of the 
   longitudinal scans the knee in neutral extended  posterior portion of the femoral 
 position. condyles. 
  Gastrocnemius-semimembran- 
  osus bursa
Fig. 1. Classical sonographic findings of crystal deposits in the knee. A. Gout. Hyperechoic enhance-
ment of the chondro-synovial interface due to monosodium urate crystal deposition on the cartilage 
surface (arrows). B. CPPD disease. Pyrophosphate crystal deposition within the hyaline cartilage 
appearing as hyperechoic spots (arrowhead) which do not generate acoustic shadowing. C. CPPD 
disease. Meniscal calcification appearing as a hyperchoic triangle-shaped area (arrowheads) between 
the femoral and tibial condyles. D. CPPD disease. Entheseal thickening and hyperechoic linear band 
without acoustic shadow located within the proximal patellar insertion into the lower pole of the patella 
(arrow). f = femur; t = tibia; pt = patellar tendon; p = patella.
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views, during flexion-extension of the 
knee, were the scans adopted to inves-
tigate the presence of meniscal calcifi-
cation. Quadriceps and patellar tendons 
and entheses were scanned with the pa-
tient supine and the lower limbs in ex-
tended neutral position. The entheseal 
thickness was measured at the point of 
maximal thickness. A detailed descrip-
tion of the scans adopted is reported in 
Table II. 
Setting parameters were standardised 
as follows:
– grey scale gain was initially set in 
order to obtain the maximal contrast 
between the different tissues under 
examination, and successively re-
duced at the lowest level allowing 
the visualisation of only hyperecho-
ic structures using bony cortex as 
reference;
– pulse repetition frequency of 900 
Hz, Doppler frequency of 7.5 MHz 
and Doppler gain to avoid random 
noise visualisation.
US image interpretation
Sonographic findings indicative of knee 
joint inflammation were investigated 
with knee extended and flexed using 
the US definitions of synovial fluid and 
synovial hypertrophy described by the 
OMERACT special interest group (23). 
Knee joint effusion was recorded when 
a minimal amount of anechoic or hyp-
oechoic suprapatellar enlargement was 
detected. Synovial hypertrophy was 
recognised by the presence of an abnor-
mally hypoechoic tissue within the joint 
cavity, different from the more echogen-
ic villous adipose tissue which appears 
rounded in shape and with clear margins. 
At hyaline cartilage level, the morpho-
structural changes used to detect the 
presence of monosodium urate and of 
CPPD crystal deposits, were the hyper-
echoic enhancement of the superficial 
margin and the hyperechoic spots within 
the cartilage layer, respectively (9) (Fig. 
1A, B). The US identification of menis-
cal calcification depended on the de-
tection of hyperechoic areas within the 
meniscal fibrocartilage showing similar 
echogenicity of the bony cortex even at 
very low levels of gain (Fig. 1C). Enthe-
seal thickening and intra-tendinous hy-
perechoic bands with or without acoustic 
shadowing were the US findings indica-
tive of enthesopathy (Fig. 1D).
Results
Two-hundred knee joints were investi-
gated in a total of 100 patients. Fifty-
one (25.5%) knee joints were found 
clinically involved, while at least one 
US finding indicative of joint inflamma-
tion was obtained in 73 (36.5%) knee 
joints. Table III illustrates the relation-
ship between US and clinical findings 
Table III. Correlation between sonographic and clinical findings indicative of knee joint 
inflammation.
A. Gout 
 Clinical findings 
US findings Presence Absence Total 
Joint effusion Presence 16 5 21
 Absence 0 39 39
Synovial hypertrophy Presence 10 0 10
 Absence 6 44 50
Intra-articular power Doppler Presence 5 0 5
 Absence 11 44 55
Total  16 44 60
B. CPPD disease 
 Clinical findings 
US findings  Presence Absence Total
Joint effusion Presence 35 17 52
 Absence 0 88 88
Synovial hypertrophy Presence 21 0 21
 Absence 14 105 119
Intra-articular power Doppler Presence 6 0 6
 Absence 29 105 134
Total  35 105 140
Table IV. Distribution of sonographic findings at different anatomical sites within the knee.
Anatomy                        US pathological findings Gout* CPPD disease*
  Number of Number of 
  knees (%) knees (%)
Knee joint Joint effusion 21 (35) 52 (37.1)
 Synovial hypertrophy 10 (16) 21 (15)
 Intra-articular PD signal 5 (8.3) 6 (4.2)
Hyaline cartilage of  Enhancement of the superficial margin 25 (41.6) 1 (0.7)
  the femoral condyles of the hyaline cartilage
 Intra-cartilaginous hyperechoic spots 0 (0) 90 (64.2)
Menisci Meniscal calcification 0 (0) 108 (77.1)
Quadriceps tendon Hyperechoic spots 3 (5) 8 (5.7)
 Hyperechoic bands without acoustic shadow 1 (1.5) 6 (4.2)
 Hyperechoic bands with acoustic shadow 2 (3.3) 2 (1.4)
 Entheseal thickening 8 (13.3) 11 (7.8)
 Intra-tendinous PD signal 8 (13.3) 7 (5)
Patellar tendon Hyperechoic spots 2 (3.3) 10 (7.1)
 Hyperechoic bands without acoustic shadow 0 (0) 8 (5.7)
 Hyperechoic bands with acoustic shadow 2 (3.3) 2 (1.4)
 Entheseal thickening 7 (11.6) 13 (9.3)
 Intra-tendinous PD signal 6 (10) 6 (4.2)
Gastrocnemius-semi- Popliteal cyst 1 (1.5) 38 (27.1)
  membranous bursa 
*The percentages have been calculated on a total of 60 and 140 knees for gout and CPPD disease, 
respectively.
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indicative of knee joint inflammation. 
The most frequent US finding indicative 
of knee joint inflammation was joint ef-
fusion, detected in 21 (35%) out of 60 
knees and in 52 (37%) out of 140 knees, 
in gout and CPPD disease, respectively. 
Ten (17%) out of 60 knees and 21 (15%) 
out of 140 knees were found positive for 
synovial hypertrophy with or without 
intra-articular power Doppler, in gout 
and CPPD disease respectively.
Table IV provides the distribution of US 
pathological findings obtained accord-
ing to the different anatomic structures 
of the knee. Sonographic evidence of 
crystal deposition within joint cartilage 
(hyaline and fibrocartilage) was more 
frequently seen than in the soft tissue 
in the knee.
Discussion
The role of US in the assessment of pa-
tients with crystal-related arthropathies 
has yet to be firmly established in rheu-
matological practice and, to date, only 
few investigators have concentrated on 
this topic (9-18).
This study demonstrated that US de-
tected a higher number of inflamed 
knee joints than clinical assessment in 
patients with crystal-related arthropa-
thies. The low number of knee joints 
with intra-articular power Doppler sig-
nal can be explained by the study de-
sign (patients were included independ-
ently from the clinical involvement of 
their knees) and by the limitations re-
lated to the technique in the assessment 
of large joints (the sensitivity of power 
Doppler in the detection of synovial 
flow is inversely related to the depth of 
the synovial tissue).
In conclusion, US signs indicative of 
knee inflammation were found more 
sensitive than clinical findings and 
US evidence of crystal aggregates at 
cartilage level resulted highly specific 
allowing for the distinction of charac-
teristic patterns of crystal deposition in 
patients with gout and CPPD disease 
(9-11). While the distribution of crys-
tal deposits at hyaline cartilage level 
permitted distinction between gout 
and CPPD disease, further studies are 
required to investigate both sensitivity 
and specificity of US features indica-
tive of crystal aggregates at both tendon 
and entheseal levels. 
Link
For further ultrasound images, please 
go to www.clinexprheumatol.org
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